Key result
Novel risk models accurately predict 1-year kidney failure and mortality in CKD patients with NSTE-ACS.
Cohort (n=17,971)
Yes
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
These externally validated competing-risk prediction models use routine clinical and kidney parameters (eGFR and albuminuria) to simultaneously estimate 1-year risks of mortality, MI readmission, and kidney failure after NSTE-ACS in patients with CKD, supporting shared decision-making around invasive management and nephrology follow-up.
Background: Patients with chronic kidney disease are at high risk of adverse outcomes after acute coronary syndrome (ACS) and need optimized treatment decisions. We derived and validated a series of risk models for predicting 1‐year mortality, readmission for myocardial infarction, and progression to kidney failure following ACS. Methods: The development cohort included adults with chronic kidney disease who had an admission for non‐ST‐segment–elevation ACS, in Alberta, Canada between April 1, 2004 and March 31, 2017. Cox proportional hazard and Fine and Gray competing risk models were externally validated and updated in a temporally distinct cohort of patients in Alberta and a geographically distinct cohort of patients with chronic kidney disease and ACS in British Columbia, Canada. Results: The derivation cohort included 11 980 patients, the temporal validation cohort 4204, and the geographic validation cohort 1787. All models showed comparable discrimination and calibration in the temporal validation cohort; comparable model performance was achieved in the geographic validation cohort after updating. In the temporal and geographic validation cohorts, respectively, discrimination was very good for kidney failure (C‐indexes, 0.93 [95% CI, 0.89–0.97] and 0.80 [95% CI, 0.78–0.82]), and modest for mortality (0.77 [95% CI, 0.75–0.78] and 0.71 [95% CI, 0.69–0.73]), and readmission for myocardial infarction (0.65 [95% CI, 0.62–0.67] and 0.57 [95% CI, 0.53–0.62]). All models were well calibrated after updating. Conclusions: We have developed, validated, and updated risk models for cardiac and renal outcomes in patients with chronic kidney disease and ACS, which can help facilitate shared decision‐making surrounding diagnostic testing, treatment, and monitoring of these patients.
Wilson et al. (2026) conducted a cohort in Non-ST-segment-elevation acute coronary syndrome in patients with chronic kidney disease (n=17,971). Multivariable risk prediction models (Cox proportional hazards and Fine and Gray competing risk models) was evaluated on 1-year all-cause mortality, readmission for myocardial infarction, composite of mortality or readmission for MI, and progression to kidney failure (C-index 0.93 (temporal) and 0.80 (geographic) for kidney failure; 0.77 and 0.71 for mortality; 0.65 and 0.57 for MI readmission, 95% CI 0.89-0.97). Multivariable risk prediction models in CKD patients with NSTE-ACS achieved C-indexes of 0.93 and 0.80 for 1-year kidney failure and 0.77 and 0.71 for mortality in validation cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: